Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

USA - NYSE:CRBD - US21871X2080

24.92 USD
-0.1 (-0.4%)
Last: 9/24/2025, 12:34:37 PM
24.9505 USD
+0.03 (+0.12%)
After Hours: 9/10/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, CRBD scores 4 out of 10 in our fundamental rating. CRBD was compared to 101 industry peers in the Financial Services industry. CRBD may be in some trouble as it scores bad on both profitability and health. CRBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CRBD was profitable.
In the past year CRBD had a positive cash flow from operations.
Each year in the past 5 years CRBD has been profitable.
CRBD had a positive operating cash flow in each of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

The Return On Assets of CRBD (-0.08%) is worse than 74.26% of its industry peers.
Looking at the Return On Equity, with a value of -2.74%, CRBD is doing worse than 78.22% of the companies in the same industry.
The Return On Invested Capital of CRBD (0.20%) is worse than 69.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBD is significantly below the industry average of 7.65%.
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROIC 0.2%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBD's Profit Margin has improved in the last couple of years.
CRBD has a Operating Margin of 7.02%. This is in the lower half of the industry: CRBD underperforms 63.37% of its industry peers.
In the last couple of years the Operating Margin of CRBD has grown nicely.
The Profit Margin and Gross Margin are not available for CRBD so they could not be analyzed.
Industry RankSector Rank
OM 7.02%
PM (TTM) N/A
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRBD is destroying value.
Compared to 1 year ago, CRBD has less shares outstanding
CRBD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRBD has a worse debt to assets ratio.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

The Debt to FCF ratio of CRBD is 6.76, which is on the high side as it means it would take CRBD, 6.76 years of fcf income to pay off all of its debts.
CRBD has a Debt to FCF ratio of 6.76. This is in the better half of the industry: CRBD outperforms 62.38% of its industry peers.
CRBD has a Debt/Equity ratio of 0.92. This is a neutral value indicating CRBD is somewhat dependend on debt financing.
CRBD's Debt to Equity ratio of 0.92 is in line compared to the rest of the industry. CRBD outperforms 47.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Altman-Z N/A
ROIC/WACC0.03
WACC7.36%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

CRBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.75%, which is quite good.
CRBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 115.54% yearly.
The Revenue for CRBD has decreased by -16.47% in the past year. This is quite bad
The Revenue has been growing by 8.01% on average over the past years. This is quite good.
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%

3.2 Future

Based on estimates for the next years, CRBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.21% on average per year.
CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.39% yearly.
EPS Next Y4.1%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
EPS Next 5Y10.21%
Revenue Next Year-7.49%
Revenue Next 2Y-1.64%
Revenue Next 3Y-0.45%
Revenue Next 5Y3.39%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.86 indicates a rather cheap valuation of CRBD.
Compared to the rest of the industry, the Price/Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 95.05% of the companies listed in the same industry.
CRBD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
CRBD is valuated cheaply with a Price/Forward Earnings ratio of 4.35.
96.04% of the companies in the same industry are more expensive than CRBD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CRBD to the average of the S&P500 Index (22.87), we can say CRBD is valued rather cheaply.
Industry RankSector Rank
PE 4.86
Fwd PE 4.35
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CRBD's Enterprise Value to EBITDA is on the same level as the industry average.
82.18% of the companies in the same industry are more expensive than CRBD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8
EV/EBITDA 18.66
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CRBD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.19
PEG (5Y)0.04
EPS Next 2Y8.75%
EPS Next 3Y11.33%

More info and screens

4

5. Dividend

5.1 Amount

CRBD has a Yearly Dividend Yield of 6.36%, which is a nice return.
CRBD's Dividend Yield is rather good when compared to the industry average which is at 5.03. CRBD pays more dividend than 84.16% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CRBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.36%

5.2 History

CRBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CRBD are negative and hence is the payout ratio. CRBD will probably not be able to sustain this dividend level.
DP-156.08%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

More info and screens

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (9/24/2025, 12:34:37 PM)

After market: 24.9505 +0.03 (+0.12%)

24.92

-0.1 (-0.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners92.72%
Inst Owner ChangeN/A
Ins Owners0.34%
Ins Owner ChangeN/A
Market Cap13.42B
Analysts79.05
Price Target31.29 (25.56%)
Short Float %0.01%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield 6.36%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP-156.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.55%
Min EPS beat(2)-0.44%
Max EPS beat(2)15.55%
EPS beat(4)3
Avg EPS beat(4)7.91%
Min EPS beat(4)-0.44%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)4.91%
EPS beat(12)10
Avg EPS beat(12)8.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.67%
Min Revenue beat(2)-11.92%
Max Revenue beat(2)-11.42%
Revenue beat(4)0
Avg Revenue beat(4)-14.95%
Min Revenue beat(4)-21.6%
Max Revenue beat(4)-11.42%
Revenue beat(8)2
Avg Revenue beat(8)-15.15%
Revenue beat(12)4
Avg Revenue beat(12)-7.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.35%
PT rev (3m)22.34%
EPS NQ rev (1m)-2.37%
EPS NQ rev (3m)-8.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.88%
Revenue NQ rev (1m)2.32%
Revenue NQ rev (3m)-4.13%
Revenue NY rev (1m)-0.69%
Revenue NY rev (3m)-5.94%
Valuation
Industry RankSector Rank
PE 4.86
Fwd PE 4.35
P/S 0.92
P/FCF 8
P/OCF 8
P/B 1.09
P/tB 1.09
EV/EBITDA 18.66
EPS(TTM)5.13
EY20.59%
EPS(NY)5.72
Fwd EY22.97%
FCF(TTM)3.12
FCFY12.5%
OCF(TTM)3.12
OCFY12.5%
SpS27.22
BVpS22.85
TBVpS22.85
PEG (NY)1.19
PEG (5Y)0.04
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROCE 0.26%
ROIC 0.2%
ROICexc 0.2%
ROICexgc 0.3%
OM 7.02%
PM (TTM) N/A
GM N/A
FCFM 11.45%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexcg growth 3Y-24.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Debt/EBITDA 8.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.78
Cash Conversion 128.19%
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.36%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
EPS Next Y4.1%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
EPS Next 5Y10.21%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%
Revenue Next Year-7.49%
Revenue Next 2Y-1.64%
Revenue Next 3Y-0.45%
Revenue Next 5Y3.39%
EBIT growth 1Y-41.6%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-7.21%
EBIT Next 3Y0.32%
EBIT Next 5YN/A
FCF growth 1Y-55.04%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-55.04%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%